Home/Pipeline/MUTI™ Knee Replacement

MUTI™ Knee Replacement

Knee Osteoarthritis

CommercialActive

Key Facts

Indication

Knee Osteoarthritis

Phase

Commercial

Status

Active

Company

Indian medtech leader delivering affordable orthopedic, cardiovascular and wound‑care devices for emerging markets.

Drug	Company	Phase	Status
Progenza	Cambium Bio	Phase 1/2a	Active
MAG200	Magellan	Phase 3	Active
DUROLANE	Bioventus	Commercial	Active
XSTEM	Xintela	Phase I/IIa	Completed (Results Reported)
Stempeucel®	Stempeutics Research	Commercial	Approved
Lipogems System for Knee Osteoarthritis	Lipogems International	Phase 3	Active
Signature Cord Prime™	Arugula Sciences	Phase 1	Active
Knee Osteoarthritis Study	Arizona Research Center	Not Specified	Active - Enrolling
4P004	4Moving Biotech	Phase 2a	Active
Lorecivivint (inferred)	Biosplice Therapeutics	Phase 3	Active
Regenerative Cell Therapy for Osteoarthritis	InGeneron	Phase 3	Active
ArthroCart	Arthro Biotech	Preclinical	Active